Crescent Biopharma, Inc. (CBIO) SEC filings

CBIO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CBIO overview →

18 measured CBIO SEC filing events.

DateHeadlineEvent5-minTo close
Form 8-K/A GYRE THERAPEUTICS, INC. For: Dec 11SEC filing · Form 8-K——
Form 8-K/A GYRE THERAPEUTICS, INC. For: Oct 30SEC filing · Form 8-K——
Form 8-K GYRE THERAPEUTICS, INC. For: Dec 11SEC filing · Form 8-K——
Form 8-K GYRE THERAPEUTICS, INC. For: Dec 06SEC filing · Form 8-K——
Form RW GYRE THERAPEUTICS, INC.SEC filing · Form RW——
Form 8-K GYRE THERAPEUTICS, INC. For: Nov 14SEC filing · Form 8-K——
Form 8-K GYRE THERAPEUTICS, INC. For: Nov 13SEC filing · Form 8-K——
Form D GYRE THERAPEUTICS, INC.SEC filing · Form D——
Form S-3 GYRE THERAPEUTICS, INC.SEC filing · Form S-3——
Form 8-K GYRE THERAPEUTICS, INC. For: Nov 06SEC filing · Form 8-K——
Form 8-K GYRE THERAPEUTICS, INC. For: Oct 30SEC filing · Form 8-K——
Form S-8 GYRE THERAPEUTICS, INC.SEC filing · Form S-8——
Form 8-K GYRE THERAPEUTICS, INC. For: Oct 27SEC filing · Form 8-K——
Form EFFECT CATALYST BIOSCIENCES,SEC filing · Form EFFECT-1.18%-9.76%
Form 8-K CATALYST BIOSCIENCES, For: Oct 26SEC filing · Form 8-K-1.18%-9.76%
Form 10-Q CATALYST BIOSCIENCES, For: Sep 30SEC filing · Form 10-Q+0.93%-0.91%
Form S-3/A CATALYST BIOSCIENCES,SEC filing · Form S-3+2.95%+21.25%
Form 8-K CATALYST BIOSCIENCES, For: Oct 20SEC filing · Form 8-K-2.00%-0.85%
Get an email when CBIO moves on news →
Keep exploring

More CBIO: earnings → · analyst actions → · CBIO overview →

Other Healthcare names and their SEC filings

Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.